BBLG FY 2018 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

FY 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

-$96

Operating Income

-$3M

Net Income

-$4M

EPS (Diluted)

$-3173.58

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$516,638

Balance Sheet

Total Assets

$1M

Total Liabilities

$10M

Stockholders' Equity

-$9M

Cash & Equivalents

$955,374

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$96	-$96	+0.0%
Operating Income	-$3M	-$3M	-6.2%
Net Income	-$4M	-$7M	+37.2%